MET as resistance factor for afatinib therapy and motility driver in gastric cancer cells

por Ebert, Karolin, Mattes, Julian, Kunzke, Thomas, Zwingenberger, Gwen, Luber, Birgit
Publicado 2019

De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry

por Prade, Verena M., Kunzke, Thomas, Feuchtinger, Annette, Rohm, Maria, Luber, Birgit, Lordick, Florian, Buck, Achim, Walch, Axel
Publicado 2020

Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines

por Kneissl, Julia, Hartmann, Anja, Pfarr, Nicole, Erlmeier, Franziska, Lorber, Thomas, Keller, Simone, Zwingenberger, Gwen, Weichert, Wilko, Luber, Birgit
Publicado 2016

Deviating HER2 test results in gastric cancer: analysis from the prospective multicenter VARIANZ study

por Kolbe, Katharina, Haffner, Ivonne, Schierle, Katrin, Maier, Dieter, Geier, Birgitta, Luber, Birgit, Bläker, Hendrik, Wittekind, Christian, Lordick, Florian
Publicado 2022

Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysi...

por Keller, Simone, Kneissl, Julia, Grabher-Meier, Verena, Heindl, Stefan, Hasenauer, Jan, Maier, Dieter, Mattes, Julian, Winter, Peter, Luber, Birgit
Publicado 2017

Model-based analysis of response and resistance factors of cetuximab treatment in gastric cancer cell lines

por Raimúndez, Elba, Keller, Simone, Zwingenberger, Gwen, Ebert, Karolin, Hug, Sabine, Theis, Fabian J., Maier, Dieter, Luber, Birgit, Hasenauer, Jan
Publicado 2020

Native glycan fragments detected by MALDI-FT-ICR mass spectrometry imaging impact gastric cancer biology and patient outcome

por Kunzke, Thomas, Balluff, Benjamin, Feuchtinger, Annette, Buck, Achim, Langer, Rupert, Luber, Birgit, Lordick, Florian, Zitzelsberger, Horst, Aichler, Michaela, Walch, Axel
Publicado 2017

Effects of trastuzumab and afatinib on kinase activity in gastric cancer cell lines

por Keller, Simone, Zwingenberger, Gwen, Ebert, Karolin, Hasenauer, Jan, Wasmuth, Jacqueline, Maier, Dieter, Haffner, Ivonne, Schierle, Katrin, Weirich, Gregor, Luber, Birgit
Publicado 2018

Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy

por Aichler, Michaela, Motschmann, Martin, Jütting, Uta, Luber, Birgit, Becker, Karen, Ott, Katja, Lordick, Florian, Langer, Rupert, Feith, Marcus, Siewert, Jörg Rüdiger, Walch, Axel
Publicado 2014

Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines

por Ebert, Karolin, Zwingenberger, Gwen, Barbaria, Elena, Keller, Simone, Heck, Corinna, Arnold, Rouven, Hollerieth, Vanessa, Mattes, Julian, Geffers, Robert, Raimúndez, Elba, Hasenauer, Jan, Luber, Birgit
Publicado 2020

Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines

por Ebert, Karolin, Zwingenberger, Gwen, Barbaria, Elena, Keller, Simone, Heck, Corinna, Arnold, Rouven, Hollerieth, Vanessa, Mattes, Julian, Geffers, Robert, Raimúndez, Elba, Hasenauer, Jan, Luber, Birgit
Publicado 2020

Metabolomic therapy response prediction in pretherapeutic tissue biopsies for trastuzumab in patients with HER2‐positive advanced gastric cancer

por Kunzke, Thomas, Hölzl, Fabian T., Prade, Verena M., Buck, Achim, Huber, Katharina, Feuchtinger, Annette, Ebert, Karolin, Zwingenberger, Gwen, Geffers, Robert, Hauck, Stefanie M., Haffner, Ivonne, Luber, Birgit, Lordick, Florian, Walch, Axel
Publicado 2021

Combining gene expression analysis of gastric cancer cell lines and tumor specimens to identify biomarkers for anti-HER therapies—the role of HAS2, SHB and HBEGF

por Ebert, Karolin, Haffner, Ivonne, Zwingenberger, Gwen, Keller, Simone, Raimúndez, Elba, Geffers, Robert, Wirtz, Ralph, Barbaria, Elena, Hollerieth, Vanessa, Arnold, Rouven, Walch, Axel, Hasenauer, Jan, Maier, Dieter, Lordick, Florian, Luber, Birgit
Publicado 2022

Biomarker analysis of cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric and oesophago-gastric junction cancer: results from a phase II trial of...

por Luber, Birgit, Deplazes, Joëlle, Keller, Gisela, Walch, Axel, Rauser, Sandra, Eichmann, Martin, Langer, Rupert, Höfler, Heinz, Hegewisch-Becker, Susanna, Folprecht, Gunnar, Wöll, Ewald, Decker, Thomas, Endlicher, Esther, Lorenzen, Sylvie, Fend, Falko, Peschel, Christian, Lordick, Florian
Publicado 2011

HER2 Expression, Test Deviations, and Their Impact on Survival in Metastatic Gastric Cancer: Results From the Prospective Multicenter VARIANZ Study

por Haffner, Ivonne, Schierle, Katrin, Raimúndez, Elba, Geier, Birgitta, Maier, Dieter, Hasenauer, Jan, Luber, Birgit, Walch, Axel, Kolbe, Katharina, Riera Knorrenschild, Jorge, Kretzschmar, Albrecht, Rau, Beate, Fischer von Weikersthal, Ludwig, Ahlborn, Miriam, Siegler, Gabriele, Fuxius, Stefan, Decker, Thomas, Wittekind, Christian, Lordick, Florian
Publicado 2021